BR0209172A - Método de detecção de doenças induzidas por glúten em uma amostra sanguìnea de um indivìduo, e kit teste para uso no método - Google Patents

Método de detecção de doenças induzidas por glúten em uma amostra sanguìnea de um indivìduo, e kit teste para uso no método

Info

Publication number
BR0209172A
BR0209172A BR0209172-0A BR0209172A BR0209172A BR 0209172 A BR0209172 A BR 0209172A BR 0209172 A BR0209172 A BR 0209172A BR 0209172 A BR0209172 A BR 0209172A
Authority
BR
Brazil
Prior art keywords
blood sample
test kit
individual
gluten
test
Prior art date
Application number
BR0209172-0A
Other languages
English (en)
Other versions
BRPI0209172B1 (pt
BRPI0209172B8 (pt
Inventor
Markku Moki
Ilma Korponay-Szabo
Original Assignee
Markku Moki
Ilma Korponay-Szabo
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=8561063&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=BR0209172(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Markku Moki, Ilma Korponay-Szabo filed Critical Markku Moki
Publication of BR0209172A publication Critical patent/BR0209172A/pt
Publication of BRPI0209172B1 publication Critical patent/BRPI0209172B1/pt
Publication of BRPI0209172B8 publication Critical patent/BRPI0209172B8/pt

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/564—Immunoassay; Biospecific binding assay; Materials therefor for pre-existing immune complex or autoimmune disease, i.e. systemic lupus erythematosus, rheumatoid arthritis, multiple sclerosis, rheumatoid factors or complement components C1-C9
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/90—Enzymes; Proenzymes
    • G01N2333/91—Transferases (2.)
    • G01N2333/91045—Acyltransferases (2.3)
    • G01N2333/91074—Aminoacyltransferases (general) (2.3.2)
    • G01N2333/9108—Aminoacyltransferases (general) (2.3.2) with definite EC number (2.3.2.-)
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/20—Dermatological disorders
    • G01N2800/202—Dermatitis
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/961—Chemistry: molecular biology and microbiology including a step of forming, releasing, or exposing the antigen or forming the hapten-immunogenic carrier complex or the antigen per se

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Hematology (AREA)
  • Engineering & Computer Science (AREA)
  • Urology & Nephrology (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Physics & Mathematics (AREA)
  • Biochemistry (AREA)
  • Cell Biology (AREA)
  • Rehabilitation Therapy (AREA)
  • Biotechnology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Rheumatology (AREA)
  • Analytical Chemistry (AREA)
  • Microbiology (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Peptides Or Proteins (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

"MéTODO DE DETECçãO DE DOENçAS INDUZIDAS POR GLúTEN EM UMA AMOSTRA SANGUìNEA DE UM INDIVìDUO, E KIT TESTE PARA USO NO MéTODO". A invenção é direcionada a um método de detectar doenças induzidas por glúten, tais como, doença celíaca e dermatite herpetiforme. Referidas doenças são indicadas pela presença de auto-anticorpos contra transglutaminase t<39>TG do tecido no sangue. O teste é realizado em uma amostra de sangue total (retirado de um doador) usando t<39>TG liberado das células do glóbulo vermelho (hemácia) da amostra sanguínea como um auto-antígeno. Os auto-antígenos liberados reagem com os auto-anticorpos na amostra e formam complexos antígeno-anticorpo, os quais são detectados. A presença de tais complexos indica a doença. A invenção também é direcionada ao uso do auto-antígeno em um teste e em um kit de teste.
BRPI0209172A 2001-04-25 2002-04-24 método de detecção de doenças induzidas por glúten em uma amostra sanguínea de um indivíduo, e kit teste para uso no método BRPI0209172B8 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FI20010868A FI20010868A0 (fi) 2001-04-25 2001-04-25 Menetelmä ja välineet gluteenin indusoimien tautien havaitsemiseksi
PCT/FI2002/000340 WO2002086509A1 (en) 2001-04-25 2002-04-24 Method and means for detecting gluten-induced diseases

Publications (3)

Publication Number Publication Date
BR0209172A true BR0209172A (pt) 2004-08-03
BRPI0209172B1 BRPI0209172B1 (pt) 2017-06-06
BRPI0209172B8 BRPI0209172B8 (pt) 2021-07-27

Family

ID=8561063

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0209172A BRPI0209172B8 (pt) 2001-04-25 2002-04-24 método de detecção de doenças induzidas por glúten em uma amostra sanguínea de um indivíduo, e kit teste para uso no método

Country Status (11)

Country Link
US (1) US7361480B2 (pt)
EP (1) EP1390753B1 (pt)
AT (1) ATE412180T1 (pt)
BR (1) BRPI0209172B8 (pt)
CA (1) CA2445102C (pt)
DE (1) DE60229513D1 (pt)
ES (1) ES2314043T3 (pt)
FI (1) FI20010868A0 (pt)
HU (1) HU229679B1 (pt)
PL (1) PL208039B1 (pt)
WO (1) WO2002086509A1 (pt)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FI20010868A0 (fi) * 2001-04-25 2001-04-25 Markku Maeki Menetelmä ja välineet gluteenin indusoimien tautien havaitsemiseksi
GB0117870D0 (en) 2001-07-21 2001-09-12 Univ Nottingham Trent Method of diagnosis and kit of parts therefor
GB0304993D0 (en) * 2003-03-05 2003-04-09 Univ Nottingham Trent Novel screening method
FR2857453B1 (fr) * 2003-07-11 2007-04-20 Covalab Procede de detection serologique de la maladie coeliaque et necessaire de diagnostic associe
BRPI0922122A2 (pt) 2008-11-30 2017-08-01 Immusant Inc composições e métodos para tratamento de doença celíaca.
WO2015038624A1 (en) 2013-09-10 2015-03-19 Immusant, Inc. Dosage of a gluten peptide composition
CA2962933A1 (en) 2014-09-29 2016-04-07 Immusant, Inc. Use of hla genetic status to assess or select treatment of celiac disease

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE461616B (sv) * 1987-05-08 1990-03-05 Biocarb Ab Foerfarande och testsats vid diagnos av iga nefropati med bestaemning av fibronektin-iga-komplex
US5200344A (en) * 1990-11-13 1993-04-06 Blaser Martin J Diagnostic testing for campylobacter jejuni or campylobacter coli infections using novel antigens
WO1994020857A1 (en) * 1993-03-11 1994-09-15 The Regents Of The University Of California Assay for humoral immunity to macromolecules
DE19630557C2 (de) * 1996-07-18 1998-07-02 Schuppan Detlef Priv Doz Dr Dr Verfahren zum Nachweis von Antikörpern aus Körperflüssigkeiten durch eine Immunreaktion mit Gewebe-Transglutaminase (tTG) sowie die Verwendung von tTG in Diagnose und Therapie
WO2001001133A2 (en) * 1999-06-28 2001-01-04 Immundiagnostik Ag Diagnosis of gluten sensitive enteropathy and other autoimmunopathies
US6703208B1 (en) * 1999-10-20 2004-03-09 Immco Diagnostics Immunological assay for detection of antibodies in celiac disease
FI20010868A0 (fi) * 2001-04-25 2001-04-25 Markku Maeki Menetelmä ja välineet gluteenin indusoimien tautien havaitsemiseksi

Also Published As

Publication number Publication date
HU229679B1 (en) 2014-04-28
US7361480B2 (en) 2008-04-22
FI20010868A0 (fi) 2001-04-25
ATE412180T1 (de) 2008-11-15
DE60229513D1 (de) 2008-12-04
BRPI0209172B1 (pt) 2017-06-06
US20040115750A1 (en) 2004-06-17
ES2314043T3 (es) 2009-03-16
PL208039B1 (pl) 2011-03-31
WO2002086509A8 (en) 2003-01-16
EP1390753A2 (en) 2004-02-25
HUP0400066A2 (hu) 2004-04-28
BRPI0209172B8 (pt) 2021-07-27
PL366996A1 (en) 2005-02-07
HUP0400066A3 (en) 2006-01-30
CA2445102C (en) 2012-01-03
WO2002086509A1 (en) 2002-10-31
EP1390753B1 (en) 2008-10-22
CA2445102A1 (en) 2002-10-31

Similar Documents

Publication Publication Date Title
Burbelo et al. Luciferase immunoprecipitation systems for measuring antibodies in autoimmune and infectious diseases
BRPI0410842B8 (pt) método in vitro para detecção da presença de um polinucleotídeo de psca em uma amostra teste derivada de um indivíduo como um indicador da presença de câncer
AU2001253079A1 (en) Methods, compositions and kits for the detection and monitoring of breast cancer
BR9814007A (pt) Dispositivo de ensaio cromatográfico e processo para detectar a presença de um analito em uma amostra de sangue
BR9912007A (pt) Composições e métodos para terapia e diagnóstico de câncer de próstata
BRPI0408928A (pt) métodos para determinar uma situação de doença em um paciente, uma situação apoptótica de células em uma amostra, e uma situação de um cáncer em um paciente
WO2010027903A3 (en) Lung cancer diagnosis
MX2013008471A (es) Metodos y aparatos para la deteccion de sensibilidad al gluten y su diferenciacion de la enfermedad celiaca.
BRPI0513596A (pt) anticorpo enriquecido para detecção de infecção micobacteriana, métodos de uso e teste diagnóstico empregando o mesmo
BR0209172A (pt) Método de detecção de doenças induzidas por glúten em uma amostra sanguìnea de um indivìduo, e kit teste para uso no método
WALDORF et al. Immunofluorescent studies in pemphigus vulgaris: Confirmatory observations and evaluation of technical considerations
DE69719737D1 (de) Immunoassay von vollblutproben
Quadeer et al. Epitopes targeted by T cells in convalescent COVID-19 patients
EA200000845A1 (ru) Ген, кодирующий новый маркер рака
AU5352901A (en) Method for quantification of akt protein expression
Morales-González¹ et al. Nrf2 modulates cell proliferation and antioxidants defenses during liver regeneration induced by partial hepatectomy
CA2643158A1 (en) METHODS FOR THE DIAGNOSIS AND PROGNOSIS OF HOST GRAFT REACTION BY MEASURING CD3 + CD4 + CD8.BETA. + CELLS IN PERIPHERAL BLOOD
ES2107528T3 (es) Ensayos de la actividad de la amilina.
ES2733002T3 (es) Método para la detección mejorada de células inmunitarias específicas de antígeno que infiltran el tejido
NZ512768A (en) Diagnostic test to detect IV cytosolic phospholipase A2 (cPLA2)
BRPI0610267B8 (pt) métodos de detecção de um estado doentio ou de uma suscetibilidade à doença em um indivíduo mamífero, e, uso do método
Lanuti et al. A flow cytometry procedure for simultaneous characterization of cell DNA content and expression of intracellular protein kinase C-ζ
ATE344454T1 (de) Oxydativer stoffwechsel in glatten muskelzellen: verfahren in beziehung dazu
WO2006086760A3 (en) Diagnostic measurement of disease
ATE391914T1 (de) Assay

Legal Events

Date Code Title Description
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
B07G Grant request does not fulfill article 229-c lpi (prior consent of anvisa) [chapter 7.7 patent gazette]

Free format text: NOTIFICACAO DE DEVOLUCAO DO PEDIDO POR NAO SE ENQUADRAR NO ART. 229-C DA LPI.

B06A Patent application procedure suspended [chapter 6.1 patent gazette]
B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B09A Decision: intention to grant [chapter 9.1 patent gazette]
B16A Patent or certificate of addition of invention granted [chapter 16.1 patent gazette]
B16C Correction of notification of the grant [chapter 16.3 patent gazette]

Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 24/04/2002, OBSERVADAS AS CONDICOES LEGAIS. PATENTE CONCEDIDA CONFORME ADI 5.529/DF, QUE DETERMINA A ALTERACAO DO PRAZO DE CONCESSAO

B21F Lapse acc. art. 78, item iv - on non-payment of the annual fees in time

Free format text: REFERENTE A 21A ANUIDADE.

B24J Lapse because of non-payment of annual fees (definitively: art 78 iv lpi, resolution 113/2013 art. 12)

Free format text: EM VIRTUDE DA EXTINCAO PUBLICADA NA RPI 2719 DE 14-02-2023 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDA A EXTINCAO DA PATENTE E SEUS CERTIFICADOS, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013.